ApoB decreased dry AMD risk (OR = 0.89, 95% CI = 0.80–0.99, p = 0.039), with trends for overall and wet AMD that were not significant (p = 0.070 and p = 0.091, respectively). Here, APOB is linked to dry age related macular degeneration.